NEW YORK, April 18 - German functional genomics startup DeveloGen has raised 40 million euros ($35 million) in a round of private financing, the company said Wednesday. 

The funds will go towards expanding the company's in-house technology platform for identifying genes related to diabetes and obesity, as well as allow the company to branch out into new areas of disease, including cardiovascular disease, said Ed Stuart, DeveloGen's COO. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.